John Han-Chih Chang, MD
Ultima Vez Modificado: 1 de noviembre del 2001
Dear OncoLink "Ask the Experts,"
I would like to know more about non-Hodgkinís Lymphoma (NHL) classified as diffuse and follicular small cleaved cells and the associated pain (due to the cancer, chemotherapy, and filgastrim). I am told that the pain is so severe that at times you can't walk, write or apply pressure to any thing.
I would also like to take this time and congratulate you on your web site. It is full of information that lets one know about the different types of cancer and all the help that is out there.
John Han-Chih Chang, MD, OncoLink Editorial Assistant, responds:
Dear L. W.
Thank you for your interest and question. We also appreciate your nice words, it is what keeps us going that we may provide a useful service to those in need.
Pain is a very subjective symptom among cancer patients. Most patients will have some sort of pain related to their malignancy if it involves the bones or other organs. It is difficult to diagnose where your pain originates based your description. NHL as with other malignancies causes pain when it involves sensitive organs such as bone (as I alluded to before), spleen, liver, in and around nerves, skin, etc. Chemotherapy can cause neuropathic pain depending on the type and the dosages utilized. Filgastrim can cause very severe pain syndromes of muscles, joints and chest.Imprima English
Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.
Oct 22, 2014
Jul 30, 2013
Aug 18, 2010
Mar 13, 2014